-
- Target Alle Acrolein (ACR) Produkte
- Acrolein (ACR)
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Acrolein Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC)
- Spezifität
- Specific for ACR-modified protein (especially FDP-lysine type derivative)
- Immunogen
- ACR-modified keyhole-lympet hemocyanine
- Klon
- F56
- Isotyp
- IgG1
-
-
- Applikationshinweise
- IHC: Recommended antibody concentration is 0.5-1.0 micro gram/mL on paraformaldehyde fixed tissue.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Frozen (100 micro g/mL antibody in 10mM PBS containing 0.1% NaN3 and 0.5% BSA). Purified by Protein-A.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
-
Expressions of lipid oxidation markers, N(ε)-hexanoyl lysine and acrolein in cisplatin-induced nephrotoxicity in rats." in: The Journal of veterinary medical science / the Japanese Society of Veterinary Science, Vol. 73, Issue 6, pp. 821-6, (2011) (PubMed).
: "
-
Expressions of lipid oxidation markers, N(ε)-hexanoyl lysine and acrolein in cisplatin-induced nephrotoxicity in rats." in: The Journal of veterinary medical science / the Japanese Society of Veterinary Science, Vol. 73, Issue 6, pp. 821-6, (2011) (PubMed).
-
- Target
- Acrolein (ACR)
- Abstract
- ACR Produkte
- Substanzklasse
- Chemical
- Hintergrund
- Acrolein (ACR) is a representative carcinogenic aldehyde found ubiquitously in the environment and formed endogenously through oxidation reactions, such as lipid peroxidation and myeloperoxidasecatalyzed amino acid oxidation. This antibody is specific for the ACR-modified protein, especially FDP-lysine type derivative.
-